ACCESSWIRE

mymediset

Share
mymediset LiveSync: mymediset and Terso Solutions Announce a New Partnership to Deliver a Revolutionary Supply Chain Platform for Live Consignment Tracking and Automation

FREIBURG, GERMANY / ACCESSWIRE / March 28, 2024 / mymediset, the leading provider of SAP solutions for the medical device industry, and Terso Solutions, the leading provider of RFID tracking solutions for the life sciences and healthcare markets, have today announced a new partnership to launch mymediset LiveSync, a revolutionary platform that will transform the way consigned inventory is identified, managed and tracked across mission-critical supply chains worldwide.

The new platform combines mymediset's cloud-based SAP automation solutions and Terso's RAIN RFID enclosures (cabinets, freezers, refrigerators) and sensors to provide real-time visibility and control of consigned products in the life sciences industries, such as medical devices, loaner kits, and pharmaceuticals. The platform, which will be launched in Q3/2024, is the first of its kind to combine live tracking and inventory data for medical and pharmaceutical consignments that is integrated into an intelligent, open, and extensible platform that provides complete visibility and control across the full product lifecycle from manufacture-to-disposal or recycling.

"This co-innovation initiative was brought together by mymediset and Terso Solutions in response to the multi-billion-dollar problem of inventory over-stocking caused by lack of real-time visibility and missing tracking data 'dead zones' that occur as consignments cycle through the different supply chain systems operated by manufacturers, distributors, and hospitals," said Michael Knauer, CEO & Founder of mymediset.

Joe Pleshek, CEO and President of Terso Solutions added: "Current industry estimates project, that several billion dollar of excess, unrecorded, or lost inventory may exist to assure product availability in mission-critical healthcare and lifesciences environments. With consignment records spanning numerous siloed systems and fragmented data sources, activities such as integrated planning, inventory rationalization and efficient automation of operations such as replenishment, disposal and recycling have so far been too costly and too complex for any one operator to resolve."

Knauer continued: "With our new mymediset LiveSync solution, we can now connect MedTech and Pharma manufacturers, distributors, and hospitals in a seamless, visible lifecycle, enabling customers to see, know, optimize, and automate every consignment wherever it is in the cycle. This provides an invaluable solution that can be used to rationalize inventory levels, reduce costs, improve patient safety, and comply with regulatory requirements and it provides the fundamental building block for our customers to create next-generation supply chains."

mymediset LiveSync Benefits:

  • Brings together the market leading capabilities of mymediset and Terso Solutions. Combining mymediset's platform, a software-as-a-service (SaaS) solution and Terso's RAIN RFID enabled enclosures and sensors, to automatically capture consignment movements in real time. Automates the entire consignment process, from order placement to invoicing, using smart algorithms and data analytics to manage complex consignment and field inventory processes inside SAP.
  • Connects all stakeholders involved in the consignment cycle and provides them with actionable insights and reports on inventory status, consumption, expiration, and replenishment.
  • Terso's RFID enclosures and sensors are connected to the cloud and transmit the inventory data to mymediset's platform in real-time, eliminating the need for manual scanning, counting, or reporting. The enclosures provide secure access control and track environmental data including temperature to ensure product integrity.
  • A seamless and scalable cloud-based SaaS solution for consignment automation that will benefit both suppliers and customers. The product will enable suppliers to increase sales, improve cash flow, and enhance customer satisfaction by ensuring the right products are available at the right time and place.
  • Enable customers to reduce inventory waste, avoid stock-outs, and improve patient outcomes by having access to the latest supplies, equipment, and devices, instantly locatable at the touch of a button.

Commenting on the partnership both CEOs pointed to the potential for customers to gain significant value from the new combination:

"We are very excited to partner with Terso Solutions and leverage their expertise and innovation in RFID technology. Together, we will offer a unique and powerful platform that will solve the challenges and inefficiencies of consignment management in the medical and life sciences industries. Our product will create value for our customers and help them achieve new levels of operational excellence and competitive advantage as they take on the challenge of running leaner, faster inventory lifecycles in next-generation supply chains driven by real-time data and assisted by AI. Two market leaders have come together to bring real-time transparency to the healthcare and life sciences industries. Finally, now we know what, where, and when products have been consumed, in real time" said Knauer.

"We are thrilled to partner with mymediset and integrate their SAP-based Enterprise SaaS platform with our RFID enabled solutions. Both mymediset and Terso have a proven track record of delivering consignment automation solutions that are trusted in the most demanding, mission-critical environments. Our product will provide a complete and end-to-end solution for consignment automation that will revolutionize the way consigned inventory is managed and tracked. With this innovative solution, We Know Now." said Pleshek.

The new product will be available for pre-order in April 2024 and will be launched in Q3 2024.

About mymediset

mymediset is the leading provider of cloud-based automation solutions for the medical device industry that specializes in managing complex loan, consignment, and field inventory processes inside SAP®. mymediset offers a platform that connects medical device and pharma manufacturers, distributors, hospitals, and clinics, and enables them to manage and track their consigned inventory in real-time. mymediset helps its customers reduce costs, increase sales, and optimize inventory levels, while ensuring compliance and patient safety.

About Terso Solutions, Inc.

Terso Solutions, Inc. is the leading provider of automated inventory management solutions for tracking high-value medical and scientific products in healthcare and life science. Terso is backed by 18 years of RFID product development and implementation experience, with a product line that includes RAIN RFID cabinets, refrigerators, freezers (-86°C to -5°C), read points, mobile solutions, and rooms. Terso has deployed over 3,500 RAIN RFID-enabled devices worldwide and provides inventory automation at over 1,000 U.S. healthcare facilities. Headquartered in Madison, WI, with additional offices in Walldorf, Germany and Tokyo, Japan, Terso Solutions, Inc. is a wholly owned subsidiary of the Promega Corporation.

For press inquiries, please contact:

mymediset:
Gloriela Rosas
LiveSync@mymediset.cloud
Phone:
North America: +1 (617) 506 9850
Europe: +49 (761) 556-5580
Terso Solutions:
Katie Anderson
katie.anderson@tersosolutions.com
Phone:+1 (608) 960-7376
For more information, please visit:
mymediset:https://mymediset.net/
https://mymediset.net/livesync/
Terso Solutions:www.tersosolutions.com

SOURCE: mymediset



View the original press release on accesswire.com

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESSWIRE

DK

Subscribe to releases from ACCESSWIRE

Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESSWIRE

Polaris Renewable Energy Announces Corporate and Bond Instrument Credit Rating8.11.2024 12:05:00 CET | Press release

TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce that international credit rating agency S&P Global Ratings has assigned corporate credit and bond instrument ratings of BB- with Stable Outlook to Polaris. About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the development, construction, acquisition, and operation of renewable energy projects in five countries in Latin America and the Caribbean. The Company's operations include a geothermal plant (~82 MW), four run-of river hydroelectric plants (~40 MW), three solar (photovoltaic) projects in operation (~35 MW) and one wind park (26 MW) following closing of the Puerto Rico acquisition. For more information, contact: Investor Relations Polaris Renewable Energy Inc. Phone: +1 647-245-7199 Email: info@PolarisREI.com SOURCE: Polaris Renewable Energy Inc. View the original press release on ac

MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion8.11.2024 10:00:00 CET | Press release

The acquisition will fuel Manamauri's global expansion with new production facilities, extended product lines, and a continued commitment to supporting emerging sports. BRUSSELS, BELGIUM / ACCESSWIRE / November 8, 2024 / MANAMAURI, the energy drink brand known for its commitment to high quality and smart pricing, has officially finalized an acquisition agreement with a subsidiary of EastBridge Global Investments. This strategic partnership empowers MANAMAURI to scale globally, remaining true to its founding values of exceptional product standards, accessibility, and support for emerging sports talent. MANAMAURI LOGO MANAMAURI LOGO "MANAMAURI was established with a clear mission: to deliver premium energy products with an intelligent pricing model, making quality accessible without compromising our values," shared a spokesperson for MANAMAURI. "We've managed to grow steadily while maintaining lean operations, focusing on efficient structures that keep unnecessary costs low. The success

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards8.11.2024 03:00:00 CET | Press release

The regional accolade recognizes commitment to global expansion and customer support LANSDALE, PA / ACCESSWIRE / November 8, 2024 / Greene Tweed, a global leader in advanced materials and high-performance solutions, has been honored as the Nottinghamshire "Excellence in International Trade" recipient of the 2024 East Midlands Chamber Business Awards, which celebrate the achievement and resilience of companies throughout the region. The East Midlands Chamber plays a vital role in connecting, supporting, and championing businesses and communities across Derbyshire, Leicestershire and Nottinghamshire in the United Kingdom. The Nottinghamshire Business Awards recently celebrated outstanding achievements in the local business community, where winners across 13 categories were announced. The "Excellence in International Trade" award specifically recognizes local businesses that excel in overseas trade. As one of five finalists in the category, Greene Tweed was selected for its robust growth

Polaris Renewable Energy Announces Fixed Income Meetings8.11.2024 01:00:00 CET | Press release

TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces today that it has engaged Pareto Securities as lead manager to arrange a series of fixed income meetings with potential eligible investors. Subject to market conditions and acceptable terms, the Company may issue a rated five-year tenor green bond on a private placement basis. The use of proceeds would be used to refinance certain existing debt facilities, the acquisition of the Punta Lima wind farm in Puerto Rico and other investments in renewable energy assets. S&P Global Ratings is expected to provide corporate and instrument ratings. The contemplated bond would be issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. The bonds have not been and will not be qualified for distribution in any province or territory of Canada. Accordingly, the bonds may not be offered or sold within any such province or terri

Innodata Reports Third Quarter 2024 Results; Record 136% Revenue Growth Year-Over-Year7.11.2024 17:00:00 CET | Press release

NEW YORK, NY / ACCESSWIRE / November 7, 2024 / INNODATA INC. (Nasdaq: INOD) today reported results for the third quarter ended September 30, 2024. Revenue of $52.2 million, 136% revenue growth year-over-year. Net income of $17.4 million, or $0.60 per basic share and $0.51 per diluted share, compared to net income of $0.4 million, or $0.01 per basic and diluted share, in the same period last year. Third quarter net income included a $5.6 million benefit as a result of recognizing a deferred tax asset that related to our accumulated net operating losses and other deferred expenses from prior periods. Adjusted EBITDA of $13.9 million, an increase of 337% from $3.2 million in the same period last year.* Cash, cash equivalents and short-term investments of $26.4 million at September 30, 2024 and $13.8 million at December 31, 2023. Guidance raised to between 88% and 92% year-over-year revenue growth for full year 2024. *Adjusted EBITDA is defined below. Jack Abuhoff, CEO, said "Innodata cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye